EANS-Adhoc: Oxygen Biotherapeutics TBI Study To Be Offered to Injured Israel-based Soldiers
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Study/Biotechnology 08.09.2010 DURHAM, NC, September 7, 2010 Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT), a development stage biomedical company focused on developing ...